A new study led by researchers at Emory University’s Rollins School of Public Health estimates that nearly 20% of U.S. residents who use pre-exposure prophylaxis (PrEP) for HIV prevention received their medication via telemedicine.
A new study led by researchers at Emory University’s Rollins School of Public Health estimates that nearly 20% of U.S. residents who use pre-exposure prophylaxis (PrEP) for HIV prevention received their medication via telemedicine.
Carlos del Rio, MD, a longtime Emory faculty member, infectious diseases physician, HIV/AIDS researcher, collaborative colleague, mentor and global health leader, has been honored with the prestigious 2024 James Shepherd Lifetime Achievement Award from the Georgia Hospital Association.
Children’s Healthcare of Atlanta and Emory University Hospital participated in a nationwide four-day, large-scale patient movement exercise designed to test and validate the nation’s ability to move patients with highly infectious diseases safely and securely to regional treatment centers.
Emory biologist Nic Vega researches how different traits in a worm population translate into transmission, an innovation that promises to provide more real-world data to develop better epidemic models.
Emory researchers have found ways to detect the neglected tropical disease schistosomiasis when other less sensitive tests cannot, leading to earlier treatment that can improve long-term outcomes.
Members of The Atlanta Opera joined local medical experts, including Emory faculty, for a discussion of how the arts have long been used as a channel for raising public awareness of pandemics or other illnesses.
Ten years ago, the first Ebola patients treated in the U.S. arrived at Emory University Hospital and Jill Morgan became the first nurse in the nation to care for them. Now, she’s using what she learned to test ways to keep pathogens from spreading.
Nearly 60 students and medical trainees from Emory’s Rollins School of Public Health and School of Medicine took part in a tabletop exercise that challenged them to work together to effectively respond to an infectious disease outbreak scenario.
The novel hepatitis C test will enable a person to be tested, and if positive for HCV, quickly connect to care and potentially begin life-saving treatment, all in a singular visit.
Now in its second year, INSPIRE offers undergraduate students from across the U.S. the opportunity to participate in infectious disease research through a 12-month mentorship program.
Discover how climate change, urbanization and lifestyle changes are fueling the rise of invasive mosquitoes.
Since 2022, bird flu has been infecting a wide variety of mammals. “You can find this trend around the world, almost anywhere you look,” says Thomas Gillespie, professor and chair of Emory’s Department of Environmental Sciences.
Emory disease ecologists show how deforestation in Costa Rica has disrupted natural systems, leading to outbreaks of rabies in cattle caused by the bite of vampire bats.
Emory researchers have mapped the distribution of the lone star tick across Georgia to help build awareness for where people are most likely to encounter the most common biting tick in the state.
Seema Lakdawala has been selected as one of the nation's foremost talented young scientists for her transformative research.
Emory Vaccine Center researchers have identified a potential Achilles heel within SARS-CoV-2. The vulnerable spot can be targeted with a peptide derived from wild boar, which maintains its antiviral activity across known variants.
The results of a novel study presented by Emory researchers during the International AIDS Society Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure.
Chemist Khalid Salaita received the 2023 Merck Future Insight Prize. The award comes with $540,000 to fund the next phase of his lab’s research into an air sensor that can continuously monitor indoor spaces for pathogens that can cause pandemics.
After three years of leadership, the principal investigators of the Emory Clinical Trials Unit are stepping down and two new leaders will take over to continue their legacy.
Adelaide Miarinjara is a medical entomologist and a postdoctoral fellow at Emory. Her focus? To unravel some of the mysteries surrounding bubonic plague and its transmission in her homeland of Madagascar.
In the Atlanta Business Chronicle's 2023 Health Care Heroes program, Linda A. McCauley, dean of the Nell Hodgson Woodruff School of Nursing at Emory University, has been named the Lifetime Achievement Award recipient and Boghuma K. Titanji has been named winner of the Health Care Innovator/Researcher category.
Emory University’s senior leadership recently recognized the efforts of the Emory COVID-19 screening team during the last two-and-a-half years of the pandemic.
Emory faculty and staff are frequently recognized for their work locally, nationally and internationally. Read a sampling of recent accolades, including awards for professional contributions and leadership appointments.
Test-and-Go COVID-19 testing will be available on Emory campuses starting in mid-December. Anyone in the Emory community is able to access these self-administered PCR tests.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
Emory University has been recognized for having some of the world’s best health sciences programs, according to U.S. News and World Report’s 2022-23 rankings of Best Global Universities.
Carlos del Rio, MD, has been announced as the new president of IDSA beginning Oct. 24. Three other Emory physicians are also receiving IDSA awards and honors.
In response to the monkeypox public health emergency, leaders from Emory Student Health Services and Counseling and Psychological Services discuss preparations for potential cases of monkeypox at Emory, prevention efforts and resources available to students.
Emory experts Jodie Guest and Carlos del Rio team up to answer questions about the new COVID-19 boosters, including who is eligible and when to get the updated shot.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
On the first episode of the new podcast One Big Question, Emory President Gregory L. Fenves talks to epidemiologist Laurel Bristow about using social media to combat misinformation about infectious diseases.
Epidemiologist Jodie Guest and David Holland, associate professor of medicine at Emory and chief clinical officer of the Fulton County Board of Health, answer questions about responding to the monkeypox outbreak without creating stigma.
The Center for AIDS Research at Emory University has received a five-year, $11.25 million award from the NIH to further its work aimed at ending the HIV epidemic through the highest-caliber translational research.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
Three faculty pairs from Emory and Georgia Tech are the inaugural recipients of AI.Humanity Seed Grant Program funds. Their work will leverage artificial intelligence to improve society and the quality of human life.
Emory University doctor of nurse practice (DNP) student John Stanton has been invited by the Georgia Department of Public Health to educate clinicians about monkeypox in a Health Alert webinar on July 21st.
Evan Anderson, an infectious disease physician at Emory and Children’s Healthcare of Atlanta, answers questions about the CDC’s recent recommendation for COVID-19 vaccines for children ages 5 and under.
A new study led by Emory University researchers reveals the need to better understand the ramifications of different therapies for the treatment of COVID-19 in immunocompromised patients with prolonged infection.
The growing international outbreak of monkeypox virus will require careful coordination among public health officials, clinicians and the community to control, say the authors of a new JAMA Viewpoint article.
In a Phase I clinical trial, investigators at the Hope Clinic of Emory Vaccine Center found a vaccine targeting mosquito-borne viruses to be safe and prompt a durable immune response.
The Atlanta Business Chronicle has selected two Emory researchers as winners of its 2022 Health Care Heroes awards.
The students of Emory's Outbreak Response Team have helped administer COVID-19 tests and vaccinations throughout Georgia. Four students joined team leader Jodie Guest to reflect on how the experience enhanced their understanding of public health outreach.
The Hope Clinic of the Emory Vaccine Center is participating in a clinical trial to evaluate the use of mRNA technology in HIV vaccines for the first time in humans.
Wilbur Lam, a principal investigator for RADx, joins epidemiologist Jodie Guest to talk about his team's work to bring new COVID-19 diagnostic tools to market and provide free testing to the community.
A facility located at 59 Executive Park in Brookhaven is home to a team of researchers testing the accuracy and safety of tests designed to detect COVID-19, as well as provide tests for the public.
Until COVID-19, more people died of TB every year than any infectious disease, especially in poorer countries. Now, a new federal grant will support scientists at Emory to further research into the air-borne bacterial disease.
The latest initiative from Human Health, which integrates Emory College’s liberal arts excellence with the university’s renowned health sciences, exposes undergrads to the science, policy, ethics and law behind vaccines and drug discovery.
Researcher and inventor Dennis Liotta is the 2022 recipient of the Perkin Medal, the highest honor a scientist can receive for contributions to applied chemistry in the U.S. His discoveries include transformative treatments for HIV and hepatitis B.
Emory epidemiologists Jodie Guest and Carlos del Rio team up to discuss the CDC’s latest recommendations for COVID-19 booster shots, including who needs a second booster and when.
In the SAVE program, researchers assess whether mutations in emerging SARS-CoV-2 variants such as Delta and Omicron affect virus transmission, severity and immunity, which in turn supports the testing of vaccines and therapeutics and guides public health responses.
A Phase 2 clinical trial evaluating second COVID-19 booster shots and various variant-targeted vaccines has begun enrolling adult participants at Emory.
Emory pulmonologist Alex Truong joins epidemiologist Jodie Guest to answer questions about long COVID, including common symptoms and potential risk factors.
Emory scientists have found Heartland virus circulating in lone star ticks in Georgia. Their research adds new evidence for how the tick-borne virus may evolve and spread geographically and from one organism to another.
Antibodies derived from Ebola survivors treated at Emory have distinctive properties, which could make the antibodies potent weapons against future outbreaks.
With the return of spring sports, Emory epidemiologist Jodie Guest and sports cardiologist Jonathan Kim discuss the impacts of COVID-19 on the heart.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
Scientists at Emory have compared the earliest SARS-CoV-2 genetic sequences detected in Georgia with virus sequences and samples from other states to learn where the first COVID-19 infections in Georgia originated.
Critically-ill patients with COVID-19 survived at a higher rate when randomized to receive the repurposed drug baricitinib, according to a study in The Lancet Respiratory Medicine. Baricitinib's use for COVID-19 was pioneered by Emory investigators at the Atlanta VAMC.
Emory experts Jodie Guest and Colleen Kraft explain the difference between rapid antigen and PCR tests and discuss how tests can be used to prevent the spread of COVID-19.
Researchers at Emory University have helped make at-home COVID-19 testing accessible, affordable and accurate. A new grant will allow them to ramp up their work "testing the tests."
For each authorized COVID-19 vaccine, mix-and-match boosters elicited similar or higher antibody responses compared to getting an additional dose of the same vaccine. Emory was among 10 institutions that participated in the study.
With so many different options on the market, Emory epidemiologists Jodie Guest and Marybeth Sexton discuss which masks are most protective against COVID-19.
Emory epidemiologists Carlos del Rio and Jodie Guest team up to discuss the latest developments regarding the COVID-19 Omicron variant.
A FDA panel voted in favor of a proposed Emergency Use Authorization for the antiviral drug molnupiravir.
Emory epidemiologists Carlos del Rio and Jodie Guest team up to answer questions about Omicron, a newly identified COVID-19 variant spreading rapidly in parts of the world.
Forty years after the first official report about what came to be known as AIDS, enormous strides have been made in developing anti-HIV drugs and reducing new infections — but efforts to find a vaccine have been unsuccessful. Emory researchers are working to change that.
As we commemorate World AIDS Day, the Emory Center for AIDS Research has been instrumental in coordinating, supporting and mentoring HIV/AIDS researchers across Emory University and beyond for more than 20 years.
The holiday season has arrived, bringing long-awaited reunions of family and friends who have been separated by the pandemic. Henry Wu, director of Emory’s TravelWell Center, joins epidemiologist Jodie Guest to discuss ways to safely travel and gather during the holidays.
Emory epidemiologists Carlos del Rio and Jodie Guest discuss topics related to COVID-19 including booster shots, vaccines for kids, natural immunity and safely gathering for the holidays.
Children ages 5-11 are now eligible to receive the Pfizer-BioNTech vaccine under an Emergency Use Authorization from the FDA. Emory teamed up with our partners at Children’s Healthcare of Atlanta to answer parents’ questions on this important development.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
Emory University and its local partners are leading the Atlanta hub for a nationwide study to identify why some people have prolonged symptoms (long COVID) or develop new or returning symptoms after an acute bout of SARS-CoV-2 infection.
Research from Emory graduate students related to COVID-19 will be highlighted during a free symposium Nov. 12. Keynote speakers are Emory infectious disease expert Carlos del Rio and MD/PhD alumnus Michael Mina.
Lee Beers, president of the American Academy of Pediatrics, joins Emory epidemiologist Jodie Guest to discuss children’s physical and mental health during the COVID-19 pandemic.
Emory infectious diseases physician Jay Varkey answers questions about CDC’s recent endorsement of Moderna and Johnson & Johnson COVID-19 booster shots.
Natalie Dean of Rollins School of Public Health answers questions about COVID-19 boosters, breakthrough infections, vaccine hesitancy and her research on other infectious diseases.
With Merck’s findings that Emory-discovered molnupiravir may significantly reduce the risk of hospitalization or death from COVID-19, Emory President Gregory L. Fenves joins epidemiologist Jodie Guest in a conversation about Emory’s history of research innovation.
Emory physician-scientist Colleen Kelley has won the 2021 Award for Excellence in HIV research. Kelley has focused her work at the intersection of science and social justice.
Emory obstetrician Denise Jamieson joins Emory epidemiologist Jodie Guest to answer questions about pregnancy and COVID-19, including why vaccination is so important for pregnant people.
Emory pulmonologist Alex Truong joins epidemiologist Jodie Guest to answer questions about long COVID, including who is at risk and what symptoms people may experience.
With new CDC recommendations allowing millions of Americans to receive Pfizer booster shots, we answer questions about who is eligible for boosters and how the CDC made its decision.
Emory infectious disease expert Evan Anderson answers questions about what Pfizer’s initial pediatric trial results mean for children under the age of 12.
Emory experts Jay Varkey and Jodie Guest define breakthrough infections, explain why they happen and discuss how to prevent them.
Emory experts Carlos del Rio and Jodie Guest explain the important differences between “third doses” and “boosters,” who needs them and whether we will ever be free of COVID-19.
Emory researchers have been involved in testing all three of the COVID-19 vaccines currently in use in the United States, along with others that may play important roles in the future.
Emory has been involved in testing all three vaccines currently in use in the U.S. Infectious disease experts Aneesh Mehta and Colleen Kelley answer questions about FDA approval, variants, masking and more.
Baricitinib, a repurposed drug that was first used against COVID-19 in the United States by Emory researchers, is emerging as a major option for treatment of hospitalized patients needing respiratory support.
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
Antibodies induced by current COVID-19 mRNA vaccines can still neutralize the Delta and Kappa variants, but at a reduced potency, according to Emory-led research.
Emory is participating in a NIAID-sponsored study evaluating immune responses to COVID-19 vaccines during pregnancy or within two months of delivery, led by principal investigator Martina Badell.
Emory Children’s Center and the Hope Clinic of Emory Vaccine Center are participating in a clinical study that assesses the potential for booster shots of COVID-19 vaccines in a “mix and match” format.
Physicians from Emory and Children’s Healthcare of Atlanta are participating in a clinical trial testing the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years. This is the same Moderna vaccine being distributed nationwide for adults.
The Hope Clinic of Emory Vaccine Center is participating in a clinical study of second-generation COVID-19 vaccines developed by the California-based company Gritstone Oncology.
New research led by Emory disease ecologist Thomas Gillespie shows that nearly half of the fecal samples from endangered wild chimpanzees contain bacteria that is resistant to a major class of antibiotics commonly used by people in the vicinity of the park.
To address the intensifying COVID-19 crisis in India, the pharmaceutical company Merck has agreed to facilitate the manufacture and distribution of molnupiravir, an investigational antiviral drug that was discovered at Emory.
NIAID has awarded Emory researchers a five-year, $11 million dollar grant to study heteroresistance, a stealthy form of antibiotic resistance that undermines the treatment of bacterial infections.
Emory University researchers have enhanced their dynamic national COVID-19 Health Equity Dashboard to provide more localized information on the impact of the pandemic in communities across Georgia.
The National Emerging Special Pathogens Training and Education Center (NETEC) – a consortium of three teaching hospitals that successfully treated patients with Ebola in 2014 – will help create and implement a nationwide plan to care for patients in future pandemics.
Emory is participating in a clinical trial testing a vaccine against the B.1.351 variant of SARS-CoV-2. The first doses were administered at the Hope Clinic of Emory Vaccine Center on Wednesday.